Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;113(12):1095-1108.
doi: 10.1007/s00347-016-0387-5.

[Therapy options for malignant eyelid tumors]

[Article in German]
Affiliations
Review

[Therapy options for malignant eyelid tumors]

[Article in German]
M Weiling et al. Ophthalmologe. 2016 Dec.

Abstract

Basal cell carcinomas are the most common malignant tumors of the eyelids. Patient history, clinical symptoms and signs, inspection, palpation and slit-lamp examination usually allow a working diagnosis; however, the clinical diagnosis requires histopathological confirmation and determination of the histopathological type. Squamous cell carcinomas, sebaceous gland carcinomas, melanomas and Merkel cell carcinomas can metastasize usually via the lymph vessels into the regional lymph nodes. Microscopically controlled excision of the primary tumor into healthy tissue is most commonly the first goal. Palpation and ultrasonography of the regional lymph nodes and also computed tomography (CT) with contrast enhancement and magnetic resonance imaging (MRI) for tumors with perineural sheath cell invasion are necessary to define the TNM stage. Non-surgical treatment options are becoming more popular in the further management of malignant eyelid tumors.

Keywords: Basal cell carcinoma; Excision; Metastasis; Nonsurgical therapy; Squamous cell carcinoma.

PubMed Disclaimer

References

    1. Ophthalmologe. 2002 Jun;99(6):490-507; quiz 508-9 - PubMed
    1. Ann Surg. 1970 Nov;172(5):902-8 - PubMed
    1. Br J Ophthalmol. 2003 Apr;87(4):514-5 - PubMed
    1. Br J Ophthalmol. 2004 Feb;88(2):236-8 - PubMed
    1. Orbit. 2010 Apr;29(2):83-7 - PubMed

MeSH terms

Substances

LinkOut - more resources